These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 28521572

  • 1. Tissue factor activity in women with preeclampsia or SGA: a potential explanation for the excessive thrombin generation in these syndromes.
    Erez O, Romero R, Vaisbuch E, Than NG, Kusanovic JP, Mazaki-Tovi S, Gotsch F, Mittal P, Dong Z, Chaiworapongsa T, Kim CJ, Nhan-Chang CL, Kim SK, Yeo L, Mazor M, Hassan SS.
    J Matern Fetal Neonatal Med; 2018 Jun; 31(12):1568-1577. PubMed ID: 28521572
    [Abstract] [Full Text] [Related]

  • 2. Tissue factor and its natural inhibitor in pre-eclampsia and SGA.
    Erez O, Romero R, Hoppensteadt D, Than NG, Fareed J, Mazaki-Tovi S, Espinoza J, Chaiworapongsa T, Kim SS, Yoon BH, Hassan SS, Gotsch F, Friel L, Vaisbuch E, Kusanovic JP.
    J Matern Fetal Neonatal Med; 2008 Dec; 21(12):855-69. PubMed ID: 19065458
    [Abstract] [Full Text] [Related]

  • 3. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death.
    Erez O, Gotsch F, Mazaki-Tovi S, Vaisbuch E, Kusanovic JP, Kim CJ, Chaiworapongsa T, Hoppensteadt D, Fareed J, Than NG, Nhan-Chang CL, Yeo L, Pacora P, Mazor M, Hassan SS, Mittal P, Romero R.
    J Matern Fetal Neonatal Med; 2009 Aug; 22(8):672-87. PubMed ID: 19736615
    [Abstract] [Full Text] [Related]

  • 4. The pattern and magnitude of "in vivo thrombin generation" differ in women with preeclampsia and in those with SGA fetuses without preeclampsia.
    Erez O, Romero R, Vaisbuch E, Kusanovic JP, Mazaki-Tovi S, Chaiworapongsa T, Gotsch F, Mittal P, Edwin SS, Nhan-Chang CL, Than NG, Kim CJ, Kim SK, Yeo L, Mazor M, Hassan SS.
    J Matern Fetal Neonatal Med; 2018 Jul; 31(13):1671-1680. PubMed ID: 28438061
    [Abstract] [Full Text] [Related]

  • 5. High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor.
    Erez O, Romero R, Vaisbuch E, Kusanovic JP, Mazaki-Tovi S, Chaiworapongsa T, Gotsch F, Fareed J, Hoppensteadt D, Than NG, Yoon BH, Edwin S, Dong Z, Espinoza J, Mazor M, Hassan SS.
    J Matern Fetal Neonatal Med; 2010 Jan; 23(1):23-33. PubMed ID: 19883261
    [Abstract] [Full Text] [Related]

  • 6. Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor.
    Godoi LC, Gomes KB, Alpoim PN, Carvalho Md, Lwaleed BA, Sant'Ana Dusse LM.
    J Thromb Thrombolysis; 2012 Jul; 34(1):1-6. PubMed ID: 22461171
    [Abstract] [Full Text] [Related]

  • 7. Retinol binding protein 4--a novel association with early-onset preeclampsia.
    Vaisbuch E, Romero R, Mazaki-Tovi S, Erez O, Kim SK, Chaiworapongsa T, Gotsch F, Than NG, Dong Z, Pacora P, Lamont R, Yeo L, Hassan SS, Kusanovic JP.
    J Perinat Med; 2010 Mar; 38(2):129-39. PubMed ID: 19708829
    [Abstract] [Full Text] [Related]

  • 8. The anti-aging factor α-klotho during human pregnancy and its expression in pregnancies complicated by small-for-gestational-age neonates and/or preeclampsia.
    Miranda J, Romero R, Korzeniewski SJ, Schwartz AG, Chaemsaithong P, Stampalija T, Yeo L, Dong Z, Hassan SS, Chrousos GP, Gold P, Chaiworapongsa T.
    J Matern Fetal Neonatal Med; 2014 Mar; 27(5):449-57. PubMed ID: 23808483
    [Abstract] [Full Text] [Related]

  • 9. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
    Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, Kusanovic JP, Gotsch F, Erez O, Mazaki-Tovi S, Gomez R, Edwin S, Chaiworapongsa T, Levine RJ, Karumanchi SA.
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
    [Abstract] [Full Text] [Related]

  • 10. Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia.
    Mittal P, Espinoza J, Hassan S, Kusanovic JP, Edwin SS, Nien JK, Gotsch F, Than NG, Erez O, Mazaki-Tovi S, Romero R.
    J Matern Fetal Neonatal Med; 2007 Sep; 20(9):651-9. PubMed ID: 17701665
    [Abstract] [Full Text] [Related]

  • 11. Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?
    Mazaki-Tovi S, Romero R, Kim SK, Vaisbuch E, Kusanovic JP, Erez O, Chaiworapongsa T, Gotsch F, Mittal P, Nhan-Chang CL, Than NG, Gomez R, Nien JK, Edwin SS, Pacora P, Yeo L, Hassan SS.
    J Matern Fetal Neonatal Med; 2010 Aug; 23(8):857-68. PubMed ID: 19900033
    [Abstract] [Full Text] [Related]

  • 12. Elevated plasma TFPI activity causes attenuated TF-dependent thrombin generation in early onset preeclampsia.
    Egan K, O'Connor H, Kevane B, Malone F, Lennon A, Al Zadjali A, Cooley S, Monteith C, Maguire P, Szklanna PB, Allen S, McCallion N, Ní Áinle F.
    Thromb Haemost; 2017 Jul 26; 117(8):1549-1557. PubMed ID: 28569919
    [Abstract] [Full Text] [Related]

  • 13. Maternal anti-protein Z antibodies in pregnancies complicated by pre-eclampsia, SGA and fetal death.
    Erez O, Romero R, Vaisbuch E, Mazaki-Tovi S, Kusanovic JP, Chaiworapongsa T, Than NG, Gotsch F, Kim CJ, Mittal P, Edwin S, Pacora P, Kim SK, Yeo L, Mazor M, Hassan SS.
    J Matern Fetal Neonatal Med; 2009 Aug 26; 22(8):662-71. PubMed ID: 19591071
    [Abstract] [Full Text] [Related]

  • 14. Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2.
    Gotsch F, Romero R, Kusanovic JP, Chaiworapongsa T, Dombrowski M, Erez O, Than NG, Mazaki-Tovi S, Mittal P, Espinoza J, Hassan SS.
    J Matern Fetal Neonatal Med; 2008 Jun 26; 21(6):389-402. PubMed ID: 18570117
    [Abstract] [Full Text] [Related]

  • 15. A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor.
    Erez O, Espinoza J, Chaiworapongsa T, Gotsch F, Kusanovic JP, Than NG, Mazaki-Tovi S, Vaisbuch E, Papp Z, Yoon BH, Han YM, Hoppensteadt D, Fareed J, Hassan SS, Romero R.
    J Matern Fetal Neonatal Med; 2008 Oct 26; 21(10):732-44. PubMed ID: 19012190
    [Abstract] [Full Text] [Related]

  • 16. Tissue factor and tissue factor pathway inhibitor in women with a past history of preeclampsia: implication for a hypercoagulable state postpregnancy.
    Lwaleed BA, Breish MO, Birch BR, Chowdhary AP, Saad RA, Perigo O, Kazmi RS, Dusse LM, Cooper AJ.
    Blood Coagul Fibrinolysis; 2014 Oct 26; 25(7):671-4. PubMed ID: 24806321
    [Abstract] [Full Text] [Related]

  • 17. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M, Gori AM, Fedi S, Chiarugi L, Simonetti I, Dabizzi RP, Prisco D, Pepe G, Abbate R, Gensini GF, Neri Serneri GG.
    Thromb Haemost; 1998 Mar 26; 79(3):495-9. PubMed ID: 9531029
    [Abstract] [Full Text] [Related]

  • 18. Tissue factor-dependent pathway in severe preeclampsia revisited: a Brazilian cohort study.
    Dusse LM, Godoi LC, Gomes KB, Carvalho Md, Lwaleed BA.
    Blood Coagul Fibrinolysis; 2016 Jun 26; 27(4):436-40. PubMed ID: 26765308
    [Abstract] [Full Text] [Related]

  • 19. Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia.
    Oggé G, Romero R, Chaiworapongsa T, Gervasi MT, Pacora P, Erez O, Kusanovic JP, Vaisbuch E, Mazaki-Tovi S, Gotsch F, Mittal P, Kim YM, Hassan SS.
    J Matern Fetal Neonatal Med; 2010 Jun 26; 23(6):476-87. PubMed ID: 19916874
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.